Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Y-mAbs Therapeutics, Inc. (YMAB)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Total revenues    43.439.840.034.946.037.1
            Revenue growth    -5.7%7.4%53.1%68.2%  
Cost of goods sold    6.95.04.02.33.02.5
Gross profit    36.534.936.032.643.034.6
            Gross margin    84.1%87.5%89.9%93.4%93.4%93.3%
Selling, general and administrative   [+]  65.365.656.054.654.151.7
Research and development    100.5101.294.693.288.586.4
Other operating expenses     0.1   -61.8
EBITDA   [+]  -128.5-131.3-114.0-52.6-37.2-41.1
            EBITDA margin    -296.0%-329.5%-285.1%-150.8%-80.7%-110.9%
Depreciation and amortization    0.90.80.80.80.60.6
EBIT   [+]  -129.4-132.1-114.9-53.4-37.8-41.7
            EBIT margin    -298.1%-331.5%-287.2%-153.1%-82.0%-112.4%
Other income (expense), net    -4.2-2.8-1.9-6.7-5.4-5.4
Pre-tax income    -133.6-135.0-116.8-122.1-105.1-109.1
Income taxes    0.00.00.00.00.00.0
            Tax rate    0.0%0.0%0.0%0.0%0.0%0.0%
Net income    -133.6-135.0-116.8-55.3-38.3-42.3
            Net margin    -307.7%-338.7%-291.9%-158.4%-83.2%-114.0%
   
Basic EPS   [+]  ($3.07)($3.10)($2.68)($1.28)($0.91)($1.02)
Diluted EPS   [+]  ($3.07)($3.10)($2.68)($1.27)($0.89)($1.01)
   
Shares outstanding (basic)   [+]  43.643.643.543.142.341.4
Shares outstanding (diluted)   [+]  43.643.643.543.742.942.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy